BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7756644)

  • 1. Generation of hematopoietic colony-forming cells from embryonic stem cells: synergy between a soluble factor from NIH-3T3 cells and hematopoietic growth factors.
    Bigas A; Martin DI; Bernstein ID
    Blood; 1995 Jun; 85(11):3127-33. PubMed ID: 7756644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells.
    Tian X; Morris JK; Linehan JL; Kaufman DS
    Exp Hematol; 2004 Oct; 32(10):1000-9. PubMed ID: 15504555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic commitment during embryonic stem cell differentiation in culture.
    Keller G; Kennedy M; Papayannopoulou T; Wiles MV
    Mol Cell Biol; 1993 Jan; 13(1):473-86. PubMed ID: 8417345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
    Verfaillie CM
    Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
    Quesniaux VF; Wehrli S; Steiner C; Joergensen J; Schuurman HJ; Herrman P; Schreier MH; Schuler W
    Blood; 1994 Sep; 84(5):1543-52. PubMed ID: 7520778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic differentiation of embryoid bodies derived from the human embryonic stem cell line SNUhES3 in co-culture with human bone marrow stromal cells.
    Kim SJ; Kim BS; Ryu SW; Yoo JH; Oh JH; Song CH; Kim SH; Choi DS; Seo JH; Choi CW; Shin SW; Kim YH; Kim JS
    Yonsei Med J; 2005 Oct; 46(5):693-9. PubMed ID: 16259069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of functional macrophages from embryonal stem cells in vitro.
    Lieschke GJ; Dunn AR
    Exp Hematol; 1995 Apr; 23(4):328-34. PubMed ID: 7534713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines.
    Wang J; Zhao HP; Lin G; Xie CQ; Nie DS; Wang QR; Lu GX
    Cell Biol Int; 2005 Aug; 29(8):654-61. PubMed ID: 15950498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primordial germ cells are capable of producing cells of the hematopoietic system in vitro.
    Rich IN
    Blood; 1995 Jul; 86(2):463-72. PubMed ID: 7541662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
    Hudak S; Hunte B; Culpepper J; Menon S; Hannum C; Thompson-Snipes L; Rennick D
    Blood; 1995 May; 85(10):2747-55. PubMed ID: 7537980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis.
    Mitjavila MT; Filippi MD; Cohen-Solal K; Le Pesteur F; Vainchenker W; Sainteny F
    Exp Hematol; 1998 Feb; 26(2):124-34. PubMed ID: 9472802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The investigation of hematopoietic capacity of HPP-CFC derived from murine embryonic stem cells in vitro and in vivo].
    Liu B; Hou CM; Wu Y; Zhang SX; Mao N
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):312-6. PubMed ID: 15969013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
    Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
    Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells.
    Berthier R; Prandini MH; Schweitzer A; Thevenon D; Martin-Sisteron H; Uzan G
    Exp Hematol; 1997 Jun; 25(6):481-90. PubMed ID: 9197325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
    Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells.
    Okada S; Nakauchi H; Nagayoshi K; Nishikawa S; Miura Y; Suda T
    Blood; 1992 Dec; 80(12):3044-50. PubMed ID: 1281687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture.
    Tsuji K; Lyman SD; Sudo T; Clark SC; Ogawa M
    Blood; 1992 Jun; 79(11):2855-60. PubMed ID: 1375116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity.
    Rowley SD; Brashem-Stein C; Andrews R; Bernstein ID
    Blood; 1993 Jul; 82(1):60-5. PubMed ID: 7686790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.